• Methyl-β-cyclodextrin: Technical Guidance for Membrane Studi

  2026-06-28

  Methyl-β-cyclodextrin is a high-purity reagent for selective extraction of cholesterol and certain lipids from cell membranes, making it essential for studies on membrane fluidity, lipid rafts, and cholesterol-dependent signaling. It is intended exclusively for laboratory research workflows and is not suitable for diagnostic or clinical applications.

• Cryoablation Reduces Tregs via TGF-β Pathway in Lung Adenoca

  2026-06-27

  Lin et al. (2025) demonstrate that cryoablation of lung adenocarcinoma alters the tumor immune microenvironment by suppressing regulatory T cells (Tregs) through inhibition of the TGF-β pathway. This mechanism, validated across single-cell, bulk RNA-seq, and in vivo models, offers new insight for optimizing immunomodulatory cancer therapies.

• Methyl-β-cyclodextrin: Technical Parameters for Membrane Stu

  2026-06-26

  Methyl-β-cyclodextrin (SKU C6939) is a high-purity biochemical reagent designed for targeted extraction of cholesterol and certain lipids from cellular membranes, crucial for membrane organization and cholesterol-dependent pathway research. It should be used exclusively in controlled research workflows, not in diagnostic, therapeutic, or clinical applications.

• Vancomycin Hydrochloride: Strategic Anchor for Translational

  2026-06-26

  This thought-leadership article offers translational researchers an advanced, mechanistically anchored perspective on deploying Vancomycin hydrochloride as a gold-standard glycopeptide antibacterial agent. By blending molecular insights with actionable protocol strategies and competitive landscape analysis, we illuminate how APExBIO’s reagent sets new standards for antibiotic resistance assays and translational infection models—empowering next-generation microbiology research.

• Recombinant Mouse SHH: Precision Tools for Urethral and Prep

  2026-06-25

  Explore the advanced applications of Recombinant Mouse Sonic Hedgehog (SHH) protein in dissecting urethral and preputial morphogenesis. This article uniquely synthesizes cutting-edge comparative evidence with practical assay strategies for developmental biology.

• Anti-HMGB1 Rabbit Monoclonal Antibody: Technical Guidance

  2026-06-25

  The Anti-HMGB1 Rabbit Monoclonal Antibody (SKU MA3057) provides targeted detection of HMGB1 in human, mouse, and rat research samples by Western blot, immunohistochemistry, or flow cytometry. It addresses the need for reliable chromatin protein detection in controlled experimental workflows but is not suitable for diagnostic or therapeutic use.

• Norovirus Selective Protein Secretion via NINJ1 and Caspase-

  2026-06-24

  This study uncovers how murine norovirus (MNoV) exploits the host protein NINJ1 to enable selective secretion of its intracellular NS1 protein, independent of conventional secretion pathways. The findings reveal a specific, caspase-3-dependent mechanism that coordinates viral evasion of host immunity and controlled plasma membrane rupture, advancing our understanding of virus-host interactions and regulated cell death.

• CUDC-907: Protocol and QC Guidance for Dual PI3K/HDAC Inhibi

  2026-06-23

  CUDC-907 addresses the need for precise, simultaneous inhibition of PI3K/AKT and HDAC pathways in cancer cell research. It is best suited for controlled in vitro workflows focused on cell signaling, cycle, and apoptosis modulation, and should not be used for diagnostic, therapeutic, or clinical applications.

• siRNA Nanoparticles Target TDRD9 to Alleviate P. aeruginosa

  2026-06-23

  This study demonstrates that hyaluronic acid-coated siRNA nanoparticles targeting TDRD9 induce neutrophil cuproptosis, significantly reducing lung injury in preclinical Pseudomonas aeruginosa models. The findings reveal a previously uncharacterized immune modulation mechanism and establish a foundation for nanoparticle-mediated therapies in multidrug-resistant bacterial pneumonia.

• HMGB1 as an Early Serum Biomarker for Diabetic Nephropathy

  2026-06-22

  This study identifies HMGB1 as a promising serum biomarker for early detection and monitoring of diabetic nephropathy, using advanced quantitative proteomics and rigorous experimental validation. The findings highlight HMGB1's superior sensitivity compared to conventional diagnostic markers, potentially transforming noninvasive DN screening strategies.

• Fluorescein TSA Fluorescence System Kit for Ultra-Sensitive

  2026-06-22

  Harness ultrasensitive amplification for immunohistochemistry, immunocytochemistry, and in situ hybridization with the Fluorescein TSA Fluorescence System Kit. This APExBIO solution empowers researchers to visualize low-abundance targets with unmatched clarity, as demonstrated in advanced nephrology models and spatial omics workflows.

• Angiotensin III: Experimental Workflows and Troubleshooting

  2026-06-21

  Angiotensin III (human, mouse) stands out as a precision tool for dissecting RAAS function and receptor signaling, thanks to its robust quality control and validated bioactivity. This guide delivers actionable protocol upgrades, advanced applications, and troubleshooting insights for cardiovascular and neuroendocrine research, leveraging recent mechanistic findings and APExBIO’s highly pure peptide.

• BMS-345541 (free base): Reliable IKK Inhibition for Cell Ass

  2026-06-20

  BMS-345541 (free base) (SKU B4655) offers bench scientists a proven, selective IKK-1/IKK-2 inhibitor for robust NF-κB pathway interrogation in inflammation, cancer, and angiogenesis models. This scenario-driven guide addresses practical challenges in viability, cytokine, and apoptosis assays, illustrating how BMS-345541 (free base) ensures reliable, reproducible data across workflows.

• Enhancing mRNA Synthesis: Scenario-Driven Insights with Pseu

  2026-06-19

  This article delivers authoritative, scenario-driven guidance for biomedical researchers seeking robust solutions in RNA stability and mRNA synthesis with pseudouridine modification. Drawing on real laboratory challenges, it demonstrates how 'Pseudo-UTP' (SKU B7972) enables reproducible, high-yield RNA workflows and supports advanced applications such as mRNA vaccine development. Evidence-based answers and protocol parameters are provided to empower confident adoption of this modified nucleotide.

• Vancomycin Hydrochloride in Selective Media: Innovations and

  2026-06-19

  Explore the advanced use of Vancomycin hydrochloride as a glycopeptide antibacterial agent in selective media and resistance assays. This article offers an in-depth analysis of innovative methodologies, with a focus on Moraxella recovery and the compound's role in shaping microbiological research.

3592 records 9/240 page Previous Next First page 上5页 678910 下5页 Last page